Trials / Completed
CompletedNCT01772160
Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy
Population Based Surveillance to Estimate the Burden of Herpes Zoster and Post-herpetic Neuralgia in Italy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 395 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect data on the incidence, complications, economic burden and impact on the quality of life in adults aged ≥ 50 years with HZ disease in Italy.
Detailed description
The surveillance/recruitment period will take approximately 2 years and once the enrolment of HZ patients has ended, the study will continue for a maximum of 9 months to allow for completion of the follow-up of potential PHN cases. The data will be captured at protocol specified time-points based on the time of enrolment of each subject.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection | HZ/PHN booklet, HZ/PHN file and logbook. HZ/PHN booklet will be completed by the patient and the HZ/PHN file and logbook will be completed by the participating general practitioner. |
Timeline
- Start date
- 2013-02-26
- Primary completion
- 2016-10-05
- Completion
- 2016-10-05
- First posted
- 2013-01-21
- Last updated
- 2020-05-22
- Results posted
- 2020-05-22
Locations
43 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01772160. Inclusion in this directory is not an endorsement.